{"id":"NCT00466193","sponsor":"Transcept Pharmaceuticals","briefTitle":"A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy and Safety of the Zolpidem Tartrate Sublingual Tablet in Adult Subjects With Insomnia Characterized by Difficulty Returning to Sleep After Awakening in the Middle-of-the-Night (MOTN)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-05","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2007-04-27","resultsPosted":"2012-01-20","lastUpdate":"2012-02-14"},"enrollment":295,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Insomnia"],"interventions":[{"type":"DRUG","name":"zolpidem tartrate sublingual tablet","otherNames":["IntermezzoÂ®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Zolpidem 3.5mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to evaluate sleep onset following administration of zolpidem tartrate sublingual tablet (Intermezzo) versus placebo in adult insomnia patients.","primaryOutcome":{"measure":"Latency to Sleep Onset After Middle-of-the-Night Awakening at Baseline","timeFrame":"Weeks -1 to 0","effectByArm":[{"arm":"Zolpidem 3.5 mg","deltaMin":68.13,"sd":null},{"arm":"Placebo","deltaMin":69.42,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":150},"commonTop":[]}}